NEW YORK, Dec. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Aehr Test Systems, Inc. (NASDAQ: AEHR).Shareholders who purchased shares of AEHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/aehr-loss-submission-form/?id=115958&from=4 CLASS PERIOD: January 9, 2024 to Marc ...

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Aehr Test Systems, Inc. ("Aehr" or the "Company") (NASDAQ: AEHR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aehr investors who were adversely affected by alleged securities fraud between January 9, 2024 and March 24, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/aehr-lawsuit-submission-for ...

NEW YORK, Dec. 4, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025.So what: If you purchased Aehr securities during the Class Period you ma ...

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Aehr Test Systems (“Aehr” or the “Company”) (NASDAQ: AEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s investors under the federal ...

SAN DIEGO, Dec. 4, 2024 /PRNewswire/ -- Robbins LLP informs investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Aehr Test Systems, Inc. (NASDAQ: AEHR) securities between January 9, 2024 and March 24, 2024. Aehr provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide.  For more information, submit a form, email attorney Aaron Dumas, Jr., or give ...

● Aehr Test Systems to Present at The LD Micro Main Event XVII Investor Conference in Los Angeles on October 29, 2024 October 21, 2024 4:05 PM EDT | Source: LD Micro Fremont, California--(Newsfile Corp. - October 21, 2024) - Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that President and CEO Gayn Erickson will be presenting at the 17th annual LD Micro Main Event Conference on Tuesday, October 29, 2024 at 2:30 pm PT at the Luxe Sunset Bou ...

Core Viewpoint - Investing in small-cap stocks can be rewarding but carries inherent risks [1] Group 1 - The discussion focuses on two small-cap stocks, each with a market capitalization of under $500 million [1] - Stock prices referenced are from the trading day of October 18, 2024 [1] - The video was published on October 20, 2024 [1]

Michael Wiggins De Oliveira is an inflection investor. This means buying into cheap companies at the moment when their narrative is changing and the business is on a path toward becoming significantly more profitable over the next year. With a focus on tech and "the Great Energy Transition (including uranium)", Michael runs a concentrated portfolio with approximately 15 to 20 stocks and an average holding period of 18 months. Through his 10+ years analyzing countless companies, Michael has accumulated outst ...

[PART I FINANCIAL INFORMATION](index=2&type=section&id=PART%20I%20FINANCIAL%20INFORMATION) [Item 1. Financial Statements (Unaudited)](index=2&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) Unaudited Q1 FY2025 financial statements reflect significant revenue and net income declines, balance sheet growth from the Incal acquisition, and reduced operating cash flow [Condensed Consolidated Balance Sheets](index=2&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets increased to **$145.9 million** driven by the Incal acquisition's goodwill and intangible assets, while cash decreased and liabilities and equity grew Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | Aug 30, 2024 | May 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $37,830 | $49,159 | | Inventories | $42,973 | $37,470 | | Goodwill | $10,353 | $0 | | Intangible assets, net | $11,854 | $0 | | **Total assets** | **$145,862** | **$127,912** | | **Liabilities & Equity** | | | | Total current liabilities | $15,420 | $10,508 | | Total liabilities | $23,379 | $16,319 | | Total shareholders' equity | $122,483 | $111,593 | | **Total liabilities and shareholders' equity** | **$145,862** | **$127,912** | [Condensed Consolidated Statements of Operations](index=3&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Q1 FY2025 saw a **36%** revenue decline to **$13.1 million** and an **85.9%** drop in net income to **$0.7 million**, with diluted EPS falling to **$0.02** Quarterly Statement of Operations (in thousands, except per share data) | Metric | Q1 FY2025 (ended Aug 30, 2024) | Q1 FY2024 (ended Aug 31, 2023) | Change YoY | | :--- | :--- | :--- | :--- | | Total Revenue | $13,119 | $20,624 | -36.4% | | Gross Profit | $7,078 | $9,981 | -29.1% | | *Gross Margin* | *54.0%* | *48.4%* | *+5.6 p.p.* | | Income from Operations | $159 | $4,115 | -96.1% | | Net Income | $660 | $4,674 | -85.9% | | Diluted EPS | $0.02 | $0.16 | -87.5% | [Condensed Consolidated Statements of Cash Flows](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Operating cash flow decreased to **$2.4 million**, while investing activities used **$10.8 million** primarily for the Incal acquisition, resulting in an **$8.5 million** net cash decrease Quarterly Cash Flow Summary (in thousands) | Cash Flow Category | Three Months Ended Aug 30, 2024 | Three Months Ended Aug 31, 2023 | | :--- | :--- | :--- | | Net cash provided by operating activities | $2,380 | $3,901 | | Net cash provided by (used in) investing activities | $(10,812) | $17,716 | | Net cash used in financing activities | $(106) | $(694) | | **Net increase (decrease) in cash** | **$(8,529)** | **$20,901** | - The primary use of cash in investing activities was **$10.6 million** for the acquisition of Incal Technology, Inc., net of cash acquired[10](index=10&type=chunk) [Notes to Condensed Consolidated Financial Statements](index=5&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes detail the **$21.9 million** Incal acquisition, significant customer concentration, a major product mix shift, and a change in fiscal year-end - On July 31, 2024, the Company acquired Incal Technology, Inc. for a total consideration of approximately **$21.9 million**, consisting of cash, restricted common stock, and an escrow payable. The acquisition resulted in the recognition of **$10.4 million** in goodwill and **$12.0 million** in intangible assets[29](index=29&type=chunk)[33](index=33&type=chunk) - The company exhibits significant customer concentration, with a single customer (Customer A) accounting for **90.8%** of total revenues for the three months ended August 30, 2024, up from **88.0%** in the prior-year period[25](index=25&type=chunk) Revenue by Product Category (in thousands) | Product Category | Q1 FY2025 | Q1 FY2024 | Change YoY | | :--- | :--- | :--- | :--- | | Systems | $60 | $8,093 | -99.3% | | Contactors | $12,094 | $11,264 | +7.4% | | Services | $965 | $1,267 | -23.8% | | **Total** | **$13,119** | **$20,624** | **-36.4%** | - Beginning June 1, 2024, the Company changed its fiscal year to a 52- or 53-week period ending on the Friday nearest May 31[15](index=15&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=15&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes the **36%** revenue decline to EV market softness, notes improved gross margin due to product mix, and highlights increased operating expenses from the Incal acquisition [Results of Operations](index=17&type=section&id=Results%20of%20Operations) Revenue declined **36%** to **$13.1 million** due to EV market softness, while gross margin improved to **54.0%** from product mix, and SG&A expenses rose due to acquisition costs - The decrease in revenue was attributed to a decline in system and service shipments, driven by recent overall softness in the demand for electric vehicles[99](index=99&type=chunk) - The increase in gross margin was primarily due to a decrease in material cost as a percentage of revenue, driven by a product mix shift toward more contactor sales[102](index=102&type=chunk) - The increase in SG&A expenses was primarily driven by **$0.5 million** in acquisition-related costs and **$0.4 million** in additional expenses from the newly acquired Incal business[104](index=104&type=chunk) [Liquidity and Capital Resources](index=19&type=section&id=Liquidity%20and%20Capital%20Resources) Cash, cash equivalents, and restricted cash totaled **$40.8 million**, with a net decrease of **$8.5 million** primarily due to the **$10.6 million** Incal acquisition and lower operating cash flow - Cash, cash equivalents, and restricted cash were **$40.8 million** as of August 30, 2024[108](index=108&type=chunk) - The decrease in cash from investing activities was primarily due to the **$10.6 million** payment to acquire Incal and the absence of maturing short-term investments, which had provided **$18.0 million** in the prior-year period[111](index=111&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=20&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) As a smaller reporting company, the company is exempt from providing quantitative and qualitative disclosures about market risk - The company is a smaller reporting company and is not required to provide quantitative and qualitative disclosures about market risk[114](index=114&type=chunk) [Item 4. Controls and Procedures](index=20&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of August 30, 2024, with no material changes to internal control over financial reporting - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of August 30, 2024[114](index=114&type=chunk) - No changes in internal control over financial reporting occurred during the quarter that have materially affected, or are reasonably likely to materially affect, the company's internal controls[115](index=115&type=chunk) [PART II OTHER INFORMATION](index=20&type=section&id=PART%20II%20OTHER%20INFORMATION) [Item 1. Legal Proceedings](index=20&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in routine legal proceedings but anticipates no material adverse effect on its financial position or results - The company accrues for litigation losses when a loss is probable and can be reasonably estimated, but is not currently aware of any proceedings expected to have a material adverse effect[116](index=116&type=chunk) [Item 1A. Risk Factors](index=20&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred to the significant risk factors previously disclosed in the company's Annual Report on Form 10-K - No material changes to the risk factors previously disclosed in the Form 10-K for the fiscal year ended May 31, 2024, have occurred[116](index=116&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=20&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered sales of equity securities or use of proceeds during the period - None[116](index=116&type=chunk) [Item 6. Exhibits](index=21&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including CEO/CFO certifications and XBRL data files

An earnings beat and upbeat commentary sent Aehr's beaten-down shares higher.Shares of Aehr Test Systems (AEHR 20.83%) rallied 18% Friday, as of 1:43 p.m. ET.The maker of wafer-level test and burn-in devices reported earnings for its August quarter yesterday, beating expectations. But more important than reported results was management's commentary that Aehr is penetrating new markets, especially artificial intelligence (AI) accelerators.Aehr is a small cap with a big opportunityLast night, Aehr reported ea ...